Full Breakdown
Palantir's NHS Data Platform Faces Political Scrutiny in the United Kingdom
6/11/2026, 8:22:48 PM
Core Event: Labour MPs Call for Cancellation of £330 Million Palantir Contract
In May 2024 the House of Commons Science, Innovation and Technology Committee, chaired by Labour Party members, urged the government to terminate Palantir Technologies’ £330 million contract to build the NHS Federated Data Platform. The committee described the partnership as a “clear mismatch” with British values.
Background & Context: From Fragmented Systems to a Centralised Platform
The NHS ran an 18-month open competition for a national data-integration solution. After assessment by 30 independent evaluators, Palantir was awarded the contract, succeeding earlier systems that relied on Microsoft and Databricks. Tom Bartlett, former deputy director for data engineering at NHS England, oversaw the rollout and characterised the predecessor as lacking password protection, audit trails, and central control.
Data & Statistics: Measured Outcomes of the Platform
- More than 110,000 surgeries removed from waiting lists.
- Approximately 300,000 patients discharged more quickly.
- Cancer diagnosis times improved, according to NHS reports.
- An early-warning algorithm, similar to one used at Tampa General Hospital, cut sepsis-related deaths by 68 % and reduced hospital stays by one-third.
Official Statements & Responses
The committee’s report cited a “clear mismatch” between Palantir’s operations and UK public-service principles. Bartlett highlighted the platform’s auditability and centralised control, likening Palantir’s access to “having the keys to a warehouse where the goods are still in sealed, unlabeled boxes.” A Guardian editorial warned that “convenience is not a basis for undermining medical confidentiality.” The Financial Times previously claimed Palantir had “unlimited access” to patient records; subsequent clarification described the claim as inaccurate.
Criticism & Opposition
Labour MPs expressed concerns that consolidating confidential medical information under a U.S. firm could create privacy vulnerabilities. Media narratives have portrayed Palantir as a “private spy agency” linked to billionaire founder Peter Thiel, and have amplified rumors of data monetisation. Additional criticism references Palantir’s partnership with Israel’s Ministry of Defence, suggesting a broader geopolitical dimension to the controversy.
Conflicting Reports & Gaps
Sources diverge on privacy risk: the committee stresses potential abuse, while NHS officials argue Palantir’s system offers superior protection compared with the predecessor. Claims of “unlimited access” to NHS data appear in the Financial Times but are denied by Palantir representatives. No independent audit of the platform’s compliance with UK data-protection law has been publicly released.
Verbatim Quotes
- “clear mismatch” with British values. — House of Commons Science, Innovation and Technology Committee
- “Convenience is not
